Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study

Cancer Research

Volumn 59, Issue 8, 1999, Pages 2011-2017

  Armes, Jane E ^a,b   Trute, Lynne ^a   White, David ^a   Southey, Melissa C ^a,b   Hammel, Fleur ^a   Tesoriero, Andrea ^a   Hutchins, Anne Marie ^a   Dite, Gillian S ^b   McCredie, Margaret R E ^c,d   Giles, Graham G ^e   Hopper, John L ^b   Venter, Deon J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER RESEARCH DIVISION   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

AGE OF ONSET; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETICS, POPULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033561620     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. D., McCredie, M. R. E., Giles, G. G., Hopper, J. L., and Venter, D. J. The histologic phenotypes of breast cancers occurring before age 40 in women with and without BRCA1 and BRCA2 germline mutations: a population-based study. Cancer (Phila.), 83: 2335-2345, 1998.
2. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349: 1505-1510, 1997.
3. Eisinger, F., Stoppa-Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent-Salomon, A., Jacquemier, J., Birnbaum, D., and Sobol, H. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56: 471-474, 1996.
4. Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., Smyth, E., Steel, C. M., Haites, N., Scott, R. J., Goldgar, D., Neuhausen, S., Daly, P. A., Ormiston, W., McManus, R., Scherneck, S., Ponder, B. A., Ford, D., Peto, J., Stoppa-Lyonnet, D., Bignon, Y-J., Struewing, J. P., Spurr, N. K., Bishop, D. T., Klijn, J. G. M., Devilee, P., Cornelisse, C. J. C. J., Lasset, C., Lenoir, G., Barkardottir, R. B., Egilsson, V., Hamann, U., Chang-Claude, J., Sobol, H., Weber, B., Stratton, M. R., and Easton, D. F. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst., 90: 1138-1145, 1998.
5. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
6. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Tonin, P., Lenoir, G. M., Serova, O., and Lynch, H. T. BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat., 44: 275-277, 1997.
7. Eisinger, F., Jacquemier, J., Charpin, C., Stoppa-Lyonnet, D., Bressac-de Paillerets, B., Peyrat, J. P., Longy, M., Guinebretiere, J. M., Sauvan, R., Noguchi, T., Birnbaum, D., and Sobol, H. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res., 58: 1588-1592, 1998.
8. Zschiesche, W., Schonborn, I., Behrens, J., Herrenknecht, K., Hartveit, F., Lilleng, P., and Birchmeier, W. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res., 17: 561-567, 1997.
9. Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A., and Koerner, F. Frequent overespression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res., 58: 2876-2880, 1998.
10. Johannsson, O. T., Idvall, I., Anderson, C., Borg, A., Barkardottir, R. B., Egilsson, V., and Olsson, H. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
11. Karp, S. E., Tonin, P. N., Begin, L. R., Martinez, J. J., Zhang, J. C., Pollak, M. N., and Foulkes, W. D. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer (Phila.), 80: 435-441, 1997.
12. Robson, M., Gilewski, T., Haas, B., Levin, D., Borgen, P., Rajan, P., Hirschaut, Y., Pressman, P., Rosen, P. P., Lesser, M. L., Norton, L., and Offit, K. BRCA-associated breast cancer in young women. J. Clin. Oncol., 16: 1642-1649, 1998.
13. Robson, M., Rajan, P., Rosen, P. P., Gilewski, T., Hirschaut, Y., Pressman, P., Haas, B., Norton, L., and Offit, K. BRCA-associated breast cancer: absence of a characteristic immunophenotype. Cancer Res., 58: 1839-1842, 1998.
14. Crook, T., Crossland, S., Crompton, M. R., Osin, P., and Gusterson, B. A. p53 mutations in BRCA1-associated familial breast cancer. Lancet, 350: 638-639, 1997.
15. Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yulung, I., Peto, J., Parker, G., Allday, M. J., Crompton, M. R., and Gusterson, B. A. p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene, 17: 1681-1689, 1998.
16. Gretarsdottir, S., Thorlacius, S., Valgardsdottir, R., Gudlaugsdottir, S., Sigurdsson, S., Steinarsdottir, M., Jonasson, J. G., Anamthawat-Jonsson, K., and Eyfjord, J. E. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res., 58: 859-862, 1998.
17. Sobol, H., Stoppa-Lyonnet, D., Bressac-De Paillerets, B., Peyrat, J. P., Guinebretiere, J-M., Jacquemier, J., Eisinger, F., and Birnbaum, D. BRCA1-p53 relationship in hereditary breast cancer. Int. J. Oncol., 10: 349-353, 1997.
18. Marcus, J. N., Watson, P., Page, D. L., and Lynch, H. T. Pathology and heredity of breast cancer in younger women. J. Natl. Cancer Inst. Monogr., 16: 23-34, 1994.
19. Kollias, J., Elston, C. W., Ellis, I. O., Robertson, J. F., and Blamey, R. W. Early-onset breast cancer-histopathological and prognostic considerations. Br. J. Cancer, 75: 1318-1323, 1997.
20. Walker, R. A., Lees, E., Webb, M. B., and Dearing, S. J. Breast carcinomas occurring in young women are different. Br. J. Cancer., 74: 1796-1800, 1996.
21. Albain, K. S., Allred, D. C., and Clark, G. M. Breast cancer outcome and predictors of outcome: are there age differentials? J. Natl. Cancer Inst. Monogr., 16: 35-42, 1994.
22. Hopper, J. L., Giles, G. G., McCredie, M. R. E., and Boyle, P. Background, rationale and protocol for a case-control-family study of breast cancer. The Breast, 3: 79-86, 1994.
23. McCredie, M. R., Dite, G. S., Giles, G. G., and Hopper, J. L. Breast cancer in Australian women under the age of 40. Cancer Causes Control, 9: 189-198, 1998.
24. Roest, P. A., Roberts, R. G., Sugino, S., van Ommen, G. J., and den Dunnen, J. T. Protein truncation test (PTT) for rapid detection of translation- terminating mutations. Hum. Mol. Genet., 2: 1719-1721, 1993.
25. Hogervorst, F. B., Cornelis, R. S., Bout, M., van Vliet, M., Oosterwijk, J. C., Olmer, R., Bakker, B., Klijn, J. G., Vasen, H. F., Meijers-Heijboer, H., Menko, F. H., Cornelisse, C. J., den Dunnen, J. T., Devilee, P., and van Ommen, G-J. B. Rapid detection of BRCA1 mutations by the protein truncation test. Nat. Genet., 10: 208-212, 1995.
26. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., and King, M. C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet., 8: 399-404, 1994.
27. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G. Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 789-92, 1995.
28. Simard, J., Tonin, P., Durocher, F., Morgan, K., Rommens, J., Gingras, S., Samson, C., Leblanc, J. F., Belanger, C., Dion, F., Liu, Q., Skolnick, S., Goldgar, D., Shattuck-Eidens, D., La Brie, F., and Narod, S. A. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families, Nat. Genet, 8: 392-398: 1994.
29. Allred, D. C., Clark, G. M., Elledge, R., Fuqua, S. A., Brown, R. W., Chamness, G. C., Osborne, C. K., and McGuire, W. L. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst., 85: 200-206, 1993.
30. Agnarsson, B. A., Jonasson, J. G., Bjornsdottir, I. B., Barkardottir, R. B., Egilsson, V., and Sigurdsson, H. Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res. Treat., 47: 121-127, 1998.
31. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
32. 1. Genes Dev., 7: 812-821, 1993.
33. Arnold, A. The cyclin D1/PRAD1 oncogene in human neoplasia. J. Invest. Med., 43: 543-549, 1995.
34. Alle, K. M., Henshall, S. M., Field, A. S., and Sutherland, R. L. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res., 4: 847-854, 1998.
35. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
36. 1-arrested human breast cancer cells. Oncogene, 12: 2315-2324, 1996.
37. Sigurdsson, H., Agnarsson, B. A., Jonasson, J. G., Bjornsdottir, I. B., Gudlaugsdottir, S., and Egilsson, V. Worse survival among breast cancer patients in families carrying the BRCA2 susceptibility gene. Breast Cancer Res. Treat., 37 (Suppl.): 33, 1996.
38. Pegram, M. D., Lipton, A., Hayes, D. F., Weber, B. L., Baselga, J. M., Tripathy, D., Baly, D., Baughman, S. A., Twaddell, T., Glaspy, J. A., and Slamon, D. J. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized antip185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol., 16: 2659-2671, 1998.
39. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
40. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386: 804-810, 1997.
41. Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M. C., and Jensen, R. A. Growth retardation and tumour inhibition by BRCA1. Nat. Genet., 12: 298-302, 1996.
42. Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995.
43. WAF1/CiP1. Nature (Lond.), 389: 187-190, 1997.
44. Zhang, H. T., Zhang, X., Zhao, H. Z., Kajino, Y., Weber, B. L., Davis, J. G., Wang, Q., O'Rourke, D. M., Zhang, H. B., Kajino, K., and Greene, M. I. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene, 14: 2863-2869, 1997.
45. Ouchi, T., Monteiro, A. N., August, A., Aaronson, S. A., and Hanafusa, H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA, 95: 2302-2306, 1998.
46. Jones, M. H., and Nakamura, Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer, 5: 89-90, 1992.
47. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
48. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Genethon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
49. Yamamoto, Y., Kishimoto, Y., Wistuba, I. I., Virmani, A. K., Vuitch, F., Gazdar, A. F., and Albores-Saavedra, J. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol. Int., 48: 265-272, 1998.
50. Sugio, K., Kishimoto, Y., Virmani, A. K., Hung, J. Y., and Gazdar, A. F. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res., 54: 5811-5815, 1994.